MS	multiple sclerosis
CNS	central nervous system
DMTs	Disease-modifying therapies
RRMS	Relapsing–remitting multiple sclerosis
EBV	Epstein–Barr virus
Ig	immunoglobulin
VCA	viral capsid antigens
EBNA	EBV nuclear antigens
RNA	ribonucleic acid
MHC	major histocompatibility complex
HLA	human leukocyte antigen
gp	glycoprotein
PRISMA	Preferred Reported Items for Systematic Reviews and Meta-Analyses
EDSS	Expanded Disability Status Scale
MRI	magnetic resonance imaging
CSF	cerebrospinal fluid
PBMCs	peripheral blood mononuclear cells
IL	interleukin
GlialCAM	glial cell adhesion molecule
CMV	cytomegalovirus
DNA	deoxyribonucleic acid
DAC HYP	daclizumab high-yield process
IFN	interferon
TNF	tumour necrosis factor
pDCs	plasmacytoid dendritic cells
EA	early antigen
GA	glatiramer acetate
DMF	dimethyl fumarate
BLyS	B-lymphocyte stimulator
APRIL	a proliferation-inducing ligand
aHSCT	autologous hematopoietic stem cell transplantation
LMP	latent membrane protein
MOG	myelin oligodendrocyte glycoprotein
MbCD	methyl-β-cyclodextrin
MBP	myelin basic protein
HHV-6	human herpes virus 6